Skip to main content

Pedigree Analysis and Risk Assessment

  • Chapter
Molecular Pathology in Clinical Practice

Abstract

The genetic family history, or pedigree, is a valuable tool for assessment of disease risk. Use of standardized symbols and nomenclature in pedigrees is recommended to ensure accurate communication of information to end users. There are common questions which should always be asked during collection of a family health history; however, questioning is often tailored for the condition under evaluation. Pedigrees may also help assess disease transmission patterns in the family which may be Mendelian (autosomal recessive, autosomal dominant, X-linked recessive, X-linked dominant, Y-linked), chromosomal, mitochondrial, or multifactorial. When atypical patterns of inheritance are seen, consideration should be given to other factors which can influence transmission including, imprinting, uniparental disomy, unstable DNA, gene-environment interactions, mosaicism, and synergistic heterozygosity. Recognition of the mode of inheritance within a family can be useful for estimating disease risk for family members or offspring. Risk assessment also may be confounded by logistical factors, such as family dynamics and limited information, or processes such as variable expression of disease, penetrance, heterogeneity, mosaicism, lyonization, or consanguinity. Many different laboratory methods are used for direct detection of genetic mutations associated with disease. When direct mutation analysis is not feasible, gene discovery or assessing risk for disease may be facilitated by linkage analysis or genome/exome sequencing. Bayesian analysis is a statistical construct that allows for the combination of incremental contributors to risk to determine an individual’s risk of developing or transmitting a disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

aCGH:

Array comparative genomic hybridization

CSGE:

Conformation-sensitive gel electrophoresis

CNVs:

Copy number variants

DGGE:

Denaturing gradient gel electrophoresis

DHPLC:

Denaturing high-performance liquid chromato-graphy

FISH:

Fluorescence in situ hybridization

HIPAA:

Health Information Privacy, Access and Accoun-tability Act

ICSI:

Intracytoplasmic sperm injection

MLPA:

Multiplex ligation-dependent probe amplification

mt:

Mitochondrial

NSGC:

National Society of Genetic Counselors

NGS:

Next-generation sequencing

OLA:

Oligonucleotide ligation assays

OMIM:

Online Mendelian Inheritance in Man

PCR:

Polymerase chain reaction

SNE:

Single-nucleotide extension

SNPs:

Single-nucleotide polymorphisms

SSCP:

Single-strand conformation polymorphism

UPD:

Uniparental disomy

References

  1. Resta R. The crane’s foot: the rise of the pedigree in human genetics. J Genet Couns. 1993;2:235–60.

    Article  CAS  PubMed  Google Scholar 

  2. Bennett RL, French KS, Resta RG, Doyle DL. Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors. J Genet Couns. 2008;17(5):424–33.

    Article  PubMed  Google Scholar 

  3. Daly M, Farmer J, Harrop-Stein C, et al. Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev. 1999;8(4 Pt 2):393–8.

    CAS  PubMed  Google Scholar 

  4. Riley BD, Culver JO, Skrzynia C, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns. 2012;21(2):151–61.

    Article  PubMed  Google Scholar 

  5. Botkin J. Protecting the privacy of family members in survey and pedigree research. JAMA. 2001;285(2):207–11.

    Article  CAS  PubMed  Google Scholar 

  6. ASHG Statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet. 1998;62(2):474–83.

    Article  Google Scholar 

  7. McKusick-Nathans Institute for Genetic Medicine JHU. Online Mendelian Inheritance in Man, OMIM®. http://omim.org. Accessed 15 Jan 2011.

  8. Deak KL, Horn SR, Rehder CW. The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: variable expressivity and genomic complexity. Clin Lab Med. 2011;31(4):543–64.

    Article  PubMed  Google Scholar 

  9. Sharp AJ. Emerging themes and new challenges in defining the role of structural variation in human disease. Hum Mutat. 2009;30(2):135–44.

    Article  CAS  PubMed  Google Scholar 

  10. Chinnery P. GeneReviews: mitochondrial disorders overview. National Center for Biotechnology Information; 2011.

    Google Scholar 

  11. Nussbaum R, McInnes R, Willard H. Thompson & Thompson genetics in medicine. Philadelphia, PA, USA: W.B. Saunders; 2001.

    Google Scholar 

  12. Young I. Introduction to risk calculation in genetic counseling. 3rd ed. Oxford: Oxford University Press; 2007.

    Google Scholar 

  13. Lerer I, Sagi M, Ben-Neriah Z, Wang T, Levi H, Abeliovich D. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: a novel founder mutation in Ashkenazi Jews. Hum Mutat. 2001;18(5):460.

    Article  CAS  PubMed  Google Scholar 

  14. Voracek M, Haubner T, Fisher ML. Recent decline in nonpaternity rates: a cross-temporal meta-analysis. Psychol Rep. 2008;103(3):799–811.

    Article  PubMed  Google Scholar 

  15. Bennett R, Motulsky A, Bittles A, et al. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2002;11:97–120.

    Article  PubMed  Google Scholar 

  16. Bruns D, Ashwood E, Burtis C. Fundamentals of molecular diagnosis. St. Louis: Saunders; 2007.

    Google Scholar 

  17. Montgomery JL, Sanford LN, Wittwer CT. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn. 2010;10(2):219–40.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang J, Chiodini R, Badr A, Zhang G. The impact of next-generation sequencing on genomics. J Genet Genomics. 2011;38(3):95–109.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Ku CS, Naidoo N, Pawitan Y. Revisiting Mendelian disorders through exome sequencing. Hum Genet. 2011;129(4):351–70.

    Article  PubMed  Google Scholar 

  20. Bick D, Dimmock D. Whole exome and whole genome sequencing. Curr Opin Pediatr. 2011;23(6):594–600.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patti Krautscheid M.S., L.C.G.C. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Krautscheid, P., LaGrave, D. (2016). Pedigree Analysis and Risk Assessment. In: Leonard, D. (eds) Molecular Pathology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-19674-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19674-9_4

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19673-2

  • Online ISBN: 978-3-319-19674-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics